about
Profound activity of the anti-cancer drug bortezomib against Echinococcus multilocularis metacestodes identifies the proteasome as a novel drug target for cestodesScreening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar EchinococcosisDevelopment of a movement-based in vitro screening assay for the identification of new anti-cestodal compounds.In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis.Treatment of echinococcosis: albendazole and mebendazole--what else?The role of arginine and arginine-metabolizing enzymes during Giardia - host cell interactions in vitro.In vitro and in vivo treatments of echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivativesEchinococcus metacestodes as laboratory models for the screening of drugs against cestodes and trematodes.Echinococcus multilocularis phosphoglucose isomerase (EmPGI): a glycolytic enzyme involved in metacestode growth and parasite-host cell interactions.Thioureides of 2-(phenoxymethyl)benzoic acid 4-R substituted: a novel class of anti-parasitic compounds.To see or not to see: non-invasive imaging for improved readout of drug treatment trials in the murine model of secondary alveolar echinococcosis.Oral treatments of Echinococcus multilocularis-infected mice with the antimalarial drug mefloquine that potentially interacts with parasite ferritin and cystatin.Host insulin stimulates Echinococcus multilocularis insulin signalling pathways and larval development.Application of an in vitro drug screening assay based on the release of phosphoglucose isomerase to determine the structure-activity relationship of thiazolides against Echinococcus multilocularis metacestodes.Activities of fenbendazole in comparison with albendazole against Echinococcus multilocularis metacestodes in vitro and in a murine infection model.Evaluation of kinase-inhibitors nilotinib and everolimus against alveolar echinococcosis in vitro and in a mouse model.Secreted Giardia intestinalis cysteine proteases disrupt intestinal epithelial cell junctional complexes and degrade chemokines.Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularisRepurposing of an old drug: In vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularisFoxp3 T Regulatory Cells as a Potential Target for Immunotherapy against Primary Infection with Echinococcus multilocularis EggsThe importance of being parasiticidal… an update on drug development for the treatment of alveolar echinococcosisEditorial overview: From farms and forests to forks? A review of diagnosis and management of globally important zoonotic Echinococcus spp. cestodesIn vitro metabolomic footprint of the Echinococcus multilocularis metacestodeActivity of Thymus capitatus essential oil components against in vitro cultured Echinococcus multilocularis metacestodes and germinal layer cells
P50
Q28542496-E1522EF0-7DDB-42C9-A884-10B0304D1030Q28550703-9156856B-E7C0-43F3-97AE-0AC0B7B720B6Q30491719-D815134B-ED3C-4D02-9AEB-06F27F09CD34Q34529138-77B8C522-C6BB-4630-B037-59E4552CFDCBQ34741945-A4FCBF05-9EA6-4CDE-B85A-26A4029809E2Q35042565-7892F05A-DF52-4F9D-A64D-543EAAB6668AQ36870795-BAB37DED-2D6E-46C5-8A3E-BEA477E26DC7Q37599990-B9052F89-EDC3-4B72-8491-7805E6742A62Q39684917-9E0A7843-AB64-476F-8AA1-BB43E177F84BQ39892057-CF0DA83C-5BEC-4D0D-853F-A36CB704FA12Q40304577-AEA805B6-BC1B-4AC8-A928-89D7B55DE198Q40987225-23178209-416E-44C2-B91F-7DC1A34EC1EAQ41952623-9650F36D-D42A-4C9B-BA06-969261518709Q43189665-25B7BD8F-2B83-4AC8-8ADC-551283CF143FQ48879579-08BC4852-64EF-4711-BE4E-41F50ED36786Q54117243-309FBAD0-4577-40E0-ADAB-6F4B7402C04AQ54221215-D557B744-7EC8-4841-8759-127B541D4E4DQ56351107-16BED18D-BD51-420E-90B4-E9D3321E7CD3Q58584921-5355E38D-1131-4F2C-9ED8-EE4856068692Q58702741-D48A4F0D-F7C0-4694-9056-E8821A4C2B88Q89869922-2CAE547F-311B-46E7-AAA3-E24A8231158EQ89869982-F79AA87B-D589-4C16-8B7F-48F57119A233Q92132644-32662146-58C8-4950-BCF6-AED51F47100BQ93035922-E5738757-ECED-4ADC-B199-F06850A15186
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0003-2672-5766
@en
name
Britta Lundström-Stadelmann
@ast
Britta Lundström-Stadelmann
@en
Britta Lundström-Stadelmann
@es
Britta Lundström-Stadelmann
@nl
type
label
Britta Lundström-Stadelmann
@ast
Britta Lundström-Stadelmann
@en
Britta Lundström-Stadelmann
@es
Britta Lundström-Stadelmann
@nl
prefLabel
Britta Lundström-Stadelmann
@ast
Britta Lundström-Stadelmann
@en
Britta Lundström-Stadelmann
@es
Britta Lundström-Stadelmann
@nl
P1053
E-8042-2011
P106
P1153
57193541730
P31
P3829
P496
0000-0003-2672-5766